176 related articles for article (PubMed ID: 16826854)
1. 18F-fluorodeoxyglucose PET/CT in cancer imaging.
Kayani I; Groves AM
Clin Med (Lond); 2006; 6(3):240-4. PubMed ID: 16826854
[No Abstract] [Full Text] [Related]
2. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
[TBL] [Abstract][Full Text] [Related]
3. [18F-FDG-PET-CT in soft tissue sarcomas: when to image?].
Rodríguez-Alfonso B; Mucientes Rasilla J; Mitjavila Casanovas M; Cardona Arboniés J; Cubedo R
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):43-9. PubMed ID: 24094372
[No Abstract] [Full Text] [Related]
4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
5. [Cancer Diagnosis - 18F-sodiumfluorid/18F-FDG-PET/CT shows promising results. ].
Lichert F
Rofo; 2013 Oct; 185(10):927. PubMed ID: 24490248
[No Abstract] [Full Text] [Related]
6. [18F-Nsodiumfluorid/18F-FDG-PET/CT shows promising results].
Lichert F
Rofo; 2013 Sep; 184(10):927. PubMed ID: 24218685
[No Abstract] [Full Text] [Related]
7. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
8. [Hybrid PET/CT in cancer imaging].
Seppänen M; Kajander S; Kemppainen J; Minn H
Duodecim; 2011; 127(11):1117-27. PubMed ID: 21755803
[TBL] [Abstract][Full Text] [Related]
9. 18-FDG PET/CT staging of ocular sebaceous cell carcinoma.
Krishna SM; Finger PT; Chin K; Lacob CE
Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):759-60. PubMed ID: 17219120
[No Abstract] [Full Text] [Related]
10. Combined 18F-Fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.
Cook GJ
J Nucl Med; 2013 Feb; 54(2):173-5. PubMed ID: 23287576
[No Abstract] [Full Text] [Related]
11. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer.
Ozis SE; Soydal C; Akyol C; Can N; Kucuk ON; Yagcı C; Erkek AB; Kuzu MA
World J Surg Oncol; 2014 Feb; 12():26. PubMed ID: 24484935
[TBL] [Abstract][Full Text] [Related]
12. "Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763).
Schinagl DA; Troost EG; Kaanders JH
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1629; author reply 1629. PubMed ID: 19515513
[No Abstract] [Full Text] [Related]
13. Positron-emission tomography/computed tomography (PET/CT) in the initial staging of primary rectal cancer.
Eglinton T; Luck A; Bartholomeusz D; Varghese R; Lawrence M
Colorectal Dis; 2010 Jul; 12(7):667-73. PubMed ID: 19486092
[TBL] [Abstract][Full Text] [Related]
14. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
15. [New trends and novel possibilities in functional medical imaging: imaging methods].
Balkay L; Emri M; Krizsán KÁ; Opposits G; Varga J
Magy Onkol; 2015 Mar; 59(1):4-9. PubMed ID: 25763907
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
[TBL] [Abstract][Full Text] [Related]
17. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
Gámez-Cenzano C; Pino-Sorroche F
PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
[TBL] [Abstract][Full Text] [Related]
18. Can whole-body MRI replace (18)F-fluorodeoxyglucose PET/CT?
Kwee TC
Lancet Oncol; 2014 Mar; 15(3):243-4. PubMed ID: 24559804
[No Abstract] [Full Text] [Related]
19. 18F-FDG PET/CT of transitional cell carcinoma.
Patil VV; Wang ZJ; Sollitto RA; Chuang KW; Konety BR; Hawkins RA; Coakley FV
AJR Am J Roentgenol; 2009 Dec; 193(6):W497-504. PubMed ID: 19933624
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET in detecting primary breast cancer.
Kumar R; Lal N; Alavi A
J Nucl Med; 2007 Oct; 48(10):1751; author reply 1752. PubMed ID: 17909261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
